Amelioration of renal ischaemia-reperfusion injury by synthetic oligopeptides related to human chorionic gonadotropin

Nephrology Dialysis Transplantation

Volumn 24, Issue 9, 2009, Pages 2701-2708

  Khan, Nisar A ^a   Susa, Denis ^a   Van Den Berg, Jan Willem ^a   Huisman, Martin ^a   Ameling, Miriam H ^a   Van Den Engel, Sandra ^a   Roest, Henk P ^a   Ijzermans, Jan N M ^a   Dik, Willem A ^a   Benner, Robbert ^a   De Bruin, Ron W F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Ischaemia reperfusion; Kidney; Peptide; Transplantation

Indexed keywords

ALANYLGLUTAMINYLGLYCINE; ALANYLGLUTAMINYLGLYCYLVALINE; CHORIONIC GONADOTROPIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; LEUCYLALANYLGLUTAMINYLVALINE; LEUCYLALANYLGLYCINE; LEUCYLGLUTAMINYLGLYCINE; LEUCYLGLUTAMINYLGLYCYLVALINE; MESSENGER RNA; METHIONYLTHREONYLARGININE; METHIONYLTHREONYLARGINYLVALINE; OLIGOPEPTIDE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VALYLLEUCYLPROLYLALANYLLEUCYLPROLINE; VALYLLEUCYLPROLYLALANYLLEUCYLPROLYLGLUTAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DOSE ESCALATION; EPITHELIUM CELL; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KIDNEY; MALE; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; REPERFUSION INJURY; RNA, MESSENGER;

EID: 69249160254     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp369     Document Type: Article

References (35)

1. Bonventre JV,Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210
2. MuyanM, Boime I. Secretion of chorionic gonadotropin from human trophoblasts. Placenta 1997; 18: 237-241
3. Birken S, Maydelman Y, Gawinowicz MA et al. Isolation and characterization of human pituitary chorionic gonadotropin. Endocrinology 1996; 137: 1402-1411
4. Yoshimoto Y, Wolfsen AR, Hirose F et al. Human chorionic gonadotropin-like material: presence in normal human tissues. Am J Obstet Gynecol 1979; 134: 729-733
5. Cole LA, Kardana A, Park SY et al. The deactivation of hCG by nicking and dissociation. J Clin Endocrinol Metab 1993; 76: 704-710
6. Khan NA, Khan A, Savelkoul HF et al. Inhibition of diabetes in NOD mice by human pregnancy factor. Hum Immunol 2001; 62: 1315-1323
7. Khan NA, Khan A, Savelkoul HF et al. Inhibition of septic shock in mice by an oligopeptide from the beta-chain of human chorionic gonadotrophin hormone. Hum Immunol 2002; 63: 1-7
8. Benner R, Khan NA. Dissection of systems, cell populations and molecules. Scand J Immunol 2005; 62(Suppl 1): 62-66
9. Alfthan H, Stenman UH. Pathophysiological importance of various molecular forms of human choriogonadotropin. Mol Cell Endocrinol 1996; 125: 107-120
10. Cole LA, Kardana A, Andrade-Gordon P et al. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. Endocrinology 1991; 129: 1559-1567
11. Kardana A, Elliott MM, Gawinowicz MA et al. The heterogeneity of human chorionic gonadotropin (hCG): I. Characterization of peptide heterogeneity in 13 individual preparations of hCG. Endocrinology 1991; 129: 1541-1550
12. Birken S,Maydelman Y, Gawinowicz MA. Preparation and analysis of the commonurinary forms of human chorionic gonadotropin. Methods 2000; 21: 3-14
13. DikWA, Nadel B, Przybylski GK et al. Different chromosomal breakpoints impact the level of LMO2 expression in T-all. Blood 2007; 110: 388-392
14. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999; 20: 114-118
15. VanDenBergHR, KhanNA,VanDerZeeMet al. Synthetic oligopeptides related to the b-subunit of human chorionic gonadotropin attenuate inflammation and liver damage after (trauma) hemorrhagic shock and resuscitation. Shock 2009; 31: 285-291
16. Kelly KJ, Williams WW Jr, Colvin RB et al. Intercellular adhesion molecule-1-deficientmice are protected against ischemic renal injury. J Clin Invest 1996; 97: 1056-1063
17. Donnahoo KK, Shames BD, Harken AH et al. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 1999; 162: 196-203
18. Takada M, Nadeau KC, Shaw GD et al. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble p-selectin ligand. J Clin Invest 1997; 99: 2682-2690
19. Kaushal GP, BasnakianAG, Shah SV. Apoptotic pathways in ischemic acute renal failure. Kidney Int 2004; 66: 500-506
20. Bocci V, Paulesu L, Pessina GP. The renal catabolic pathways of cytokines. Contrib Nephrol 1993; 101: 55-60
21. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003; 14: 1549-1558
22. Lipinski CA, Lombardo F, Dominy BWet al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001; 46: 3-26
23. Bevilacqua MP, Stengelin S, GimbroneMAJr et al.Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160-1165
24. Collins T, Read MA, Neish AS et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappaBand cytokine-inducible enhancers. Faseb J 1995; 9: 899-909
25. Shannon MF, Coles LS, Attema J et al. The role of architectural transcription factors in cytokine gene transcription. J Leukoc Biol 2001; 69: 21-32
26. Burne MJ, Daniels F, El Ghandour A et al. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 108: 1283-1290
27. Takada M, Chandraker A, Nadeau KC et al. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997; 100: 1199-1203
28. Park P, Haas M, Cunningham PN et al. Injury in renal ischemiareperfusion is independent from immunoglobulins and t lymphocytes. Am J Physiol Renal Physiol 2002; 282: F352-F357
29. Scholzen T, Gerdes J. The ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182: 311-322
30. Renshaw AA, Loughlin KR, Dutta A. Cyclin a and mib1 (ki67) as markers of proliferative activity in primary renal neoplasms. Mod Pathol 1998; 11: 963-966
31. Comperat E, Ferlicot S, Camparo P et al. Expression of epidermal growth factor receptor and proliferative activity of cyst epithelium in human renal cystic diseases. Urol Int 2006; 76: 269-273
32. Vinuesa E, Sola A, Jung M et al. Lipocalin-2-induced renal regeneration depends on cytokines. Am J Physiol Renal Physiol 2008; 295: F1554-F1562
33. Exponential biotherapies announces completion of EA-230 phase 1b single dose human lps challenge, press release, 2005. http//:www.expobio.com/docs/10- 20-05.pdf
34. Exponential biotherapies announces completion of EA-230 phase 1a multi-dose human safety trials, press release, 2006. http//:www.expobio.com/ docs/3-10-06.pdf
35. LapthornAJ, Harris DC, LittlejohnAet al. Crystal structure of human chorionic gonadotropin. Nature 1994; 369: 455-461